Destiny Pharma Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • DEST
Stock Symbol
  • Share Price
  • $0.84
  • (As of Friday Closing)

Destiny Pharma General Information

Description

Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Contact Information

Formerly Known As
Destiny Consultants
Ownership Status
Publicly Held
Financing Status
Pending Transaction (M&A)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
LON
Primary Office
  • Sussex Innovation Centre, Science Park Square
  • Falmer
  • Brighton BN1 9SB
  • England, United Kingdom
+44 01273 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Destiny Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.84 $0.89 $0.37 - $1.50 $39.1M 44M 83.8K -$0.14

Destiny Pharma Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 10,440 13,227 14,581 81,597
Revenue 0 0 0 0
EBITDA (7,628) (7,102) (8,100) (4,146)
Net Income (6,350) (6,007) (6,890) (3,834)
Total Assets 7,638 11,220 16,570 23,086
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Destiny Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Destiny Pharma‘s full profile, request access.

Request a free trial

Destiny Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the tr
Drug Discovery
Brighton, United Kingdom
9 As of 2019
000.00
000000000 000.00

00000000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna al
0000 000000000
Bangalore, India
00 As of 0000
0000
00000000000 0000

00 00000

psum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
0000 000000000
Paris, France
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Destiny Pharma Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bugworks Research Venture Capital-Backed Bangalore, India 00 0000 00000000000 0000
00 00000000 Private Debt Financed Paris, France 00 000.00 000000000 000.00
000 000000000 Venture Capital-Backed Bellshill, United Kingdom 0 000.00 0000000000 0 000.00
00000000 Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
00000000 Angel-Backed Boston, MA 0 00.000 0000000000 00.000
You’re viewing 5 of 25 competitors. Get the full list »

Destiny Pharma Executive Team (8)

Name Title Board Seat Contact Info
Neil Clark Chief Executive Officer & Board Member
Shaun Claydon Chief Financial Officer, Finance & Board Member
Ian Hayter Director, Project
William Love Ph.D Board Member & Executive
Jesus Moreno Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Destiny Pharma Board Members (12)

Name Representing Role Since
Neil Clark Destiny Pharma Chief Executive Officer & Board Member 000 0000
Peter Morgan Destiny Pharma Board Member 000 0000
Shaun Claydon Destiny Pharma Chief Financial Officer, Finance & Board Member 000 0000
William Love Ph.D Destiny Pharma Board Member & Executive 000 0000
You’re viewing 4 of 12 board members. Get the full list »

Destiny Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Destiny Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Destiny Pharma‘s full profile, request access.

Request a free trial